Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.
about
A zinc finger HIT domain-containing protein, ZNHIT-1, interacts with orphan nuclear hormone receptor Rev-erbbeta and removes Rev-erbbeta-induced inhibition of apoCIII transcriptionHuman aldose reductase expression accelerates diabetic atherosclerosis in transgenic miceLarge animal models of cardiovascular diseaseAnimal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesInflammation and metabolic dysfunction: links to cardiovascular diseasesSevere Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein ReceptorA computational model for the analysis of lipoprotein distributions in the mouse: translating FPLC profiles to lipoprotein metabolismImpaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoproteinAcetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy statusPTG gene deletion causes impaired glycogen synthesis and developmental insulin resistanceGenetic background determines response to hemostasis and thrombosis.A murine model of obesity with accelerated atherosclerosis.Quantitative trait locus mapping of genetic modifiers of metabolic syndrome and atherosclerosis in low-density lipoprotein receptor-deficient mice: identification of a locus for metabolic syndrome and increased atherosclerosis on chromosome 4.Mouse models of the metabolic syndrome.Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.Inflammation, a link between obesity and cardiovascular diseaseDoes early mismatched nutrition predispose to hypertension and atherosclerosis, in male mice?Emerging role of adipokines as mediators in atherosclerosis.Leptin receptor-induced STAT3-independent signaling pathways are protective against atherosclerosis in a murine model of obesity and hyperlipidemiaEffects of LDL Receptor Modulation on Lymphatic FunctionAnimal models of cardiovascular diseasesMelanocortin signaling in the CNS directly regulates circulating cholesterol.Left ventricular dysfunction with reduced functional cardiac reserve in diabetic and non-diabetic LDL-receptor deficient apolipoprotein B100-only miceLong-term hyperphagia and caloric restriction caused by low- or high-density husbandry have differential effects on zebrafish postembryonic development, somatic growth, fat accumulation and reproductionNutritional recovery with a soybean diet after weaning reduces lipogenesis but induces inflammation in the liver in adult rats exposed to protein restriction during intrauterine life and lactation.Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia.Diabetes, lipids, and adipocyte secretagogues.Obesity and altered glucose metabolism impact HDL composition in CETP transgenic mice: a role for ovarian hormones.Genetic basis of atherosclerosis: insights from mice and humansEffects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease.Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin.Leptin treatment inhibits the progression of atherosclerosis by attenuating hypercholesterolemia in type 1 diabetic Ins2(+/Akita):apoE(-/-) mice.Role of leptin in atherogenesis.Swine models of type 2 diabetes mellitus: insulin resistance, glucose tolerance, and cardiovascular complications.Role of leptin in the cardiovascular and endocrine complications of metabolic syndrome.Effects of leptin on cardiovascular physiologyMetabolic syndrome manifestations in classic congenital adrenal hyperplasia: do they predispose to atherosclerotic cardiovascular disease and secondary polycystic ovary syndrome?Effect of Leptin Replacement on PCSK9 in ob/ob Mice and Female Lipodystrophic Patients.Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.Sulforaphane improves dysregulated metabolic profile and inhibits leptin-induced VSMC proliferation: Implications toward suppression of neointima formation after arterial injury in western diet-fed obese mice
P2860
Q24294901-EAB96ADB-EA0F-4D05-B345-5C1CDC1C7CE7Q24530027-9FCC4549-6DC7-4E56-BC0E-F85C6A58FB67Q26766350-D3DF1E90-4D7C-464E-A348-C9FB88B8EDECQ26822630-13AF08E0-B42A-44BD-B4E5-C5D8BD7A9157Q26851186-7BE1DB5D-CCB5-4ED4-9ECE-3E0E0D61EC06Q28468525-33AF0A7B-41A8-4645-BD39-89B43FB97AE4Q28538300-FD620652-8B84-4474-9DC6-B43B853C7CB0Q28583188-B11627B2-9418-43D5-B681-8ADB1CC12467Q28586350-3218260C-1900-4BFE-9269-108906AAF4F3Q30453008-8E957A48-EBDC-49A9-9B4F-83B15D85C0BAQ33259449-F957349A-190E-4FF8-8C90-A775E979682CQ33611086-C3D4BD7F-FD6C-41FE-8216-6CC238849DCAQ33637168-40801B34-5658-4A0C-A14B-72F348FFCD87Q33849244-085D04F1-172B-43DA-859A-5125FBF334C6Q34002877-DAEE74E5-D3A3-4290-A738-EB3736D78978Q34089724-982E1BD0-17DC-4AA7-90C0-235AC80C37FEQ34115292-96E2E770-1243-478E-A541-78BD49CFAFB6Q34427067-D4D81D6E-DB8B-46FC-8FDD-BBA161C9496DQ34478852-B5381B9B-0146-4B18-B14F-C64020863F9CQ34530204-1AEEB445-8CBE-4A13-9222-38FE2903C229Q34591282-CEE83BB1-AFA6-4050-BB7E-F75E32C17765Q34999515-E6C7C0F0-184D-470B-8EC7-449DF8BC1E44Q35121259-877F813A-C29D-4326-83AB-3164F1D89EA9Q35208528-28C8973C-4A6C-41D8-A47C-458725C81D1BQ35373126-AB5A37AD-D1EE-45FF-87EA-9B7645DC59BDQ35567134-65F1AB92-902E-4ECF-B030-A1E3B0EB9C0BQ35723496-0B9B05DF-E51A-46BB-AF1E-4374261362F5Q35747749-B2C03725-116F-4569-B7AF-02A319C17FB4Q35975437-B4C8827E-78AA-470B-A707-26560EA9FD34Q36216863-08D0006F-681C-4F2B-ABE7-CCB8D3B325FFQ36367336-2E7A2526-E962-4513-861E-61E739F97655Q36413085-0B3DDD6F-2625-45F7-B93C-4DFEF23F065BQ36508445-D0F6A273-EB57-4E20-9C08-CD6551CAC0FBQ36521113-1248B975-F2D6-4B3B-A2C1-C5DAFD936A22Q36616558-A60608A0-BA92-42B4-B329-4F39B574183AQ36632723-423CE953-A195-4988-9E47-FBD30E14B1ACQ36674821-8A27B8CE-83B1-4176-861F-6E87B09BADA2Q36753809-77B04ECB-A964-486D-AC85-6FA3A2369A53Q36895502-136CD763-2022-4243-AA19-1CB2D647215AQ36923666-EA80126C-2FED-4849-B8DC-C86BBDBE7BFE
P2860
Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Severe hypercholesterolemia, h ...... density lipoprotein receptor.
@en
type
label
Severe hypercholesterolemia, h ...... density lipoprotein receptor.
@en
prefLabel
Severe hypercholesterolemia, h ...... density lipoprotein receptor.
@en
P2093
P2860
P50
P921
P356
P1476
Severe hypercholesterolemia, h ...... w density lipoprotein receptor
@en
P2093
Amemiya-Kudo M
Ishibashi S
Matsuzaka T
Namatame I
P2860
P304
37402-37408
P356
10.1074/JBC.M010176200
P407
P577
2001-07-09T00:00:00Z